Zobrazeno 51 - 60
of 338
pro vyhledávání: '"Hans A. Messner"'
Autor:
Vikas Gupta, Joseph Brandwein, Andre C. Schuh, Hans A. Messner, Karen W.L. Yee, Jeffrey H. Lipton, Aaron D. Schimmer, Mark D. Minden, Susan Y. Kao, Wei Xu
Publikováno v:
British Journal of Haematology. 143:738-743
We report a single center experience in treating 24 consecutive patients > or = 60 years old for aplastic anaemia (AA) with immunosuppressive therapy (IST). The main outcomes of interest were the tolerability and toxicity of IST, response rate and su
Autor:
Lakshmi Sriharsha, Suzanne Kamel-Reid, Hans A. Messner, Gizelle Popradi, Hong Chang, D.H. Kim, Jeffrey H. Lipton
Publikováno v:
Cancer. 113:772-781
BACKGROUND. Although deletion of the derivative chromosome 9 (der 9; del-der 9) carries a poor prognosis in patients with chronic myeloid leukemia (CML) who are treated with hydroxyurea or interferon, its significance in patients on imatinib mesylate
Autor:
Jeffrey H. Lipton, Deepali Kumar, Mark D. Minden, John Kuruvilla, Vikas Gupta, Hans A. Messner, Yee Soo Chae, Sang Kyun Sohn, Dong Hwan Kim
Publikováno v:
Clinical Transplantation. 22:770-779
Varicella-Zoster virus infection (VZV) has a high incidence post-allogeneic peripheral blood stem cell transplant (PBSCT). However, data regarding long-term acyclovir prophylaxis for VZV prevention are limited. We evaluated the clinical efficacy of l
Autor:
Hans A. Messner
Publikováno v:
Bone Marrow Transplantation. 42:S14-S17
During the past decade it has become apparent that patients can be transplanted successfully after preparation with regimens of reduced intensity. Reduced intensity preparations have resulted in lower morbidity and mortality during the pre-engraftmen
Autor:
Vikas Gupta, Jeffrey H. Lipton, Hans A. Messner, Gregory R. Pond, Richard W. Tsang, John Kuruvilla
Publikováno v:
Biology of Blood and Marrow Transplantation. 14(7):775-782
Allogeneic stem cell transplantation (Allo-SCT) remains an option for patients with follicular lymphoma (FL). We performed a retrospective analysis to examine long-term disease control and treatment-related mortality (TRM) in a group of patients that
Autor:
Kenneth Mah, Mireille Khoraych, Jeffrey H. Lipton, Hans A. Messner, Ghada Khoraych, Katherine Krawiec, France Lefebvre, Gerald M. Devins
Publikováno v:
Psychology, Health & Medicine. 13:337-345
According to the Person x Situation theoretical framework, people adjust their coping to address the unique challenges of encountered stressors. Whether their strategies fit or appropriately address these stressor challenges influences adjustment. We
Autor:
Vikas Gupta, John Kuruvilla, Suzanne Kamel-Reid, Wei Xu, Jeffrey H. Lipton, Deborah M. Siegal, Mark D. Minden, Robert Sutherland, Hans A. Messner
Publikováno v:
Bone Marrow Transplantation. 42:51-56
Prevention of GVHD is one of the most desirable goals of BMT in aplastic anemia (AA). We reviewed the medical records of 24 consecutive patients treated with BMT for acquired AA using two different GVHD prevention strategies. Ten patients were given
Autor:
Pierre Laneuville, Hans A. Messner, Gizelle Popradi, Lakshmi Sriharsha, Dong Hwan Kim, Jeffrey H. Lipton
Publikováno v:
Clinical Leukemia. 2:55-63
Background Dasatinib is a potent inhibitor of multiple tyrosine kinases, including Bcr-Abl and Src. Pleural effusions have occurred at an incidence of 21% in phase II studies with dasatinib. We investigated the incidence, clinical course, and managem
Autor:
Nicholas Mitsakakis, Joseph Brandwein, Hans A. Messner, Jeffrey H. Lipton, Vikas Gupta, Karen W.L. Yee, Aaron D. Schimmer, Mark D. Minden, Arwa A.N. Abdelhameed, Kathy Chun, Suzanne Kamel-Reid, Gregory R. Pond, Andre C. Schuh
Publikováno v:
Cancer. 112:1513-1521
BACKGROUND Evaluation of therapeutic outcomes and risk factors was undertaken for patients with primary solid tumors (PST) developing acute leukemia or myelodysplasia (MDS) as a second malignancy. METHODS In all, 131 consecutive patients presenting t
Autor:
Maggie Hong Chen, Brenda Welsh, Jeff Lipton, Deborah M. Siegal, Atul Humar, Hans A. Messner, Deepali Kumar, Isabel Cobos
Publikováno v:
Clinical Infectious Diseases. 45:1576-1582
Background Adult allogeneic hematopoietic stem cell transplant (HSCT) recipients are at high risk of invasive pneumococcal disease but have suboptimal responses to the recommended pneumococcal polysaccharide vaccine (PPV23). Pneumococcal conjugate va